Literature DB >> 24636853

Hypotension following patent ductus arteriosus ligation: the role of adrenal hormones.

Ronald I Clyman1, Andrea Wickremasinghe2, T Allen Merritt3, Tabitha Solomon3, Patrick McNamara4, Amish Jain4, Jaideep Singh5, Alison Chu5, Shahab Noori6, Krishnamurthy Sekar6, Pascal M Lavoie7, Joshua T Attridge8, Jonathan R Swanson8, Maria Gillam-Krakauer9, Jeff Reese9, Sara DeMauro10, Brenda Poindexter11, Sue Aucott12, Monique Satpute12, Erika Fernandez13, Richard J Auchus14.   

Abstract

OBJECTIVE: To test the hypothesis that an impaired adrenal response to stress might play a role in the hypotension that follows patent ductus arteriosus (PDA) ligation. STUDY
DESIGN: We performed a multicenter study of infants born at <32 weeks' gestation who were about to undergo PDA ligation. Serum adrenal steroids were measured 3 times: before and after a cosyntropin (1.0 μg/kg) stimulation test (performed before the ligation), and at 10-12 hours after the ligation. A standardized approach for diagnosis and treatment of postoperative hypotension was followed at each site. A modified inotrope score (1 × dopamine [μg/kg/min] + 1 × dobutamine) was used to monitor the catecholamine support an infant received. Infants were considered to have catecholamine-resistant hypotension if their greatest inotrope score was >15.
RESULTS: Of 95 infants enrolled, 43 (45%) developed hypotension and 14 (15%) developed catecholamine-resistant hypotension. Low postoperative cortisol levels were not associated with the overall incidence of hypotension after ligation. However, low cortisol levels were associated with the refractoriness of the hypotension to catecholamine treatment. In a multivariate analysis: the OR for developing catecholamine-resistant hypotension was OR 36.6, 95% CI 2.8-476, P = .006. Low cortisol levels (in infants with catecholamine-resistant hypotension) were not attributable to adrenal immaturity or impairment; their cortisol precursor concentrations were either low or unchanged, and their response to cosyntropin was similar to infants without catecholamine-resistant hypotension.
CONCLUSION: Infants with low cortisol concentrations after PDA ligation are likely to develop postoperative catecholamine-resistant hypotension. We speculate that decreased adrenal stimulation, rather than an impaired adrenal response to stimulation, may account for the decreased production.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24636853      PMCID: PMC4035426          DOI: 10.1016/j.jpeds.2014.01.058

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  33 in total

1.  Effect of dose on response to adrenocorticotropin in extremely low birth weight infants.

Authors:  Kristi L Watterberg; Michele L Shaffer; Jeffery S Garland; Elizabeth H Thilo; Mark C Mammel; Robert J Couser; Susan W Aucott; Corinne L Leach; Cynthia H Cole; Jeffrey S Gerdes; Henry J Rozycki; Conra Backstrom
Journal:  J Clin Endocrinol Metab       Date:  2005-09-13       Impact factor: 5.958

2.  Use of targeted neonatal echocardiography to prevent postoperative cardiorespiratory instability after patent ductus arteriosus ligation.

Authors:  Amish Jain; Mohit Sahni; Afif El-Khuffash; Emad Khadawardi; Arvind Sehgal; Patrick J McNamara
Journal:  J Pediatr       Date:  2011-11-03       Impact factor: 4.406

3.  Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants.

Authors:  S al Saedi; H Dean; W Dent; C Cronin
Journal:  J Pediatr       Date:  1995-06       Impact factor: 4.406

4.  Response to ACTH in the newborn.

Authors:  S Thomas; J F Murphy; J Dyas; M Ryalls; I A Hughes
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

5.  Serum cortisol concentrations in ill preterm infants less than 30 weeks gestational age.

Authors:  M Heckmann; S A Wudy; D Haack; F Pohlandt
Journal:  Acta Paediatr       Date:  2000-09       Impact factor: 2.299

6.  Implementation of a liquid chromatography tandem mass spectrometry assay for eight adrenal C-21 steroids and pediatric reference data.

Authors:  Alexandra E Kulle; Maik Welzel; Paul-Martin Holterhus; Felix G Riepe
Journal:  Horm Res Paediatr       Date:  2013-01-17       Impact factor: 2.852

7.  Acute hemodynamic decompensation following patent ductus arteriosus ligation in premature infants.

Authors:  Matthew T Harting; Martin L Blakely; Charles S Cox; Regina Lantin-Hermoso; Richard J Andrassy; Kevin P Lally
Journal:  J Invest Surg       Date:  2008 May-Jun       Impact factor: 2.533

8.  Adrenal function in preterm infants undergoing patent ductus arteriosus ligation.

Authors:  Afif EL-Khuffash; Patrick J McNamara; Anie Lapointe; Amish Jain
Journal:  Neonatology       Date:  2013-04-25       Impact factor: 4.035

9.  Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia.

Authors:  K L Watterberg; S M Scott
Journal:  Pediatrics       Date:  1995-01       Impact factor: 7.124

10.  Risk factors predicting vasopressor use after patent ductus arteriosus ligation.

Authors:  Furqan Moin; Kathleen A Kennedy; Fernando R Moya
Journal:  Am J Perinatol       Date:  2003-08       Impact factor: 1.862

View more
  13 in total

1.  Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.

Authors:  Ronald I Clyman; Melissa Liebowitz
Journal:  J Pediatr       Date:  2017-07-11       Impact factor: 4.406

2.  Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.

Authors:  Melissa Liebowitz; Ronald I Clyman
Journal:  J Pediatr       Date:  2017-04-07       Impact factor: 4.406

3.  CYP2C9*2 is associated with indomethacin treatment failure for patent ductus arteriosus.

Authors:  Sydney R Rooney; Elaine L Shelton; Ida Aka; Christian M Shaffer; Ronald I Clyman; John M Dagle; Kelli Ryckman; Tamorah R Lewis; Jeff Reese; Sara L Van Driest; Prince J Kannankeril
Journal:  Pharmacogenomics       Date:  2019-08       Impact factor: 2.533

4.  Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation.

Authors:  S Noori; P McNamara; A Jain; P M Lavoie; A Wickremasinghe; T A Merritt; T Solomon; K Sekar; J T Attridge; J R Swanson; M Gillam-Krakauer; J Reese; B B Poindexter; M Brook; R J Auchus; R I Clyman
Journal:  J Perinatol       Date:  2014-08-14       Impact factor: 2.521

5.  Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals.

Authors:  Jonathan L Slaughter; Patricia B Reagan; Roopali V Bapat; Thomas B Newman; Mark A Klebanoff
Journal:  Eur J Pediatr       Date:  2016-02-15       Impact factor: 3.183

6.  Effects of Prophylactic Indomethacin on Vasopressor-Dependent Hypotension in Extremely Preterm Infants.

Authors:  Melissa Liebowitz; Jane Koo; Andrea Wickremasinghe; Isabel Elaine Allen; Ronald I Clyman
Journal:  J Pediatr       Date:  2016-12-01       Impact factor: 4.406

7.  The impact of a dedicated patent ductus arteriosus ligation team on neonatal health-care outcomes.

Authors:  M H F Resende; K More; D Nicholls; J Ting; A Jain; P J McNamara
Journal:  J Perinatol       Date:  2016-01-14       Impact factor: 2.521

8.  Antenatal Betamethasone: A Prolonged Time Interval from Administration to Delivery Is Associated with an Increased Incidence of Severe Intraventricular Hemorrhage in Infants Born before 28 Weeks Gestation.

Authors:  Melissa Liebowitz; Ronald I Clyman
Journal:  J Pediatr       Date:  2016-08-08       Impact factor: 4.406

Review 9.  Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?

Authors:  P Vali; S Lakshminrusimha; A Pelech; M Underwood; F Ing
Journal:  J Perinatol       Date:  2019-09-27       Impact factor: 3.225

Review 10.  Circulatory Insufficiency and Hypotension Related to the Ductus Arteriosus in Neonates.

Authors:  Danielle R Rios; Soume Bhattacharya; Philip T Levy; Patrick J McNamara
Journal:  Front Pediatr       Date:  2018-03-15       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.